In addition, pharmacologic inhibition of ACE2 exacerbates cardiac hypertrophy and circulating Ang(1–7) levels in transgenic rats are associated with reduced cardiac hypertrophy and fibrosis following isoproterenol infusion [50,51]. This evidence concerns the gene ACE2 and cardiac hypertrophy.